Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition have?

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition has 576 citations in the OpenAlex counts ScholarIQ stores.

When was Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition published?

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition has 2016 year in the ScholarIQ index.

What is the open-access status of Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition?

Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition has hybrid oa status in the ScholarIQ index.

What is the DOI of Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition?

The DOI for Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition is on the source record.

What is the PMID of Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition?

The PMID for Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition is on the source record.

What is the OpenAlex record for Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition?

The OpenAlex for Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition is on the source record.